Literature DB >> 17591073

Risk factors for massive blood loss during liver resection for hepatocellular carcinoma in patients with cirrhosis.

Shoji Kubo1, Shigekazu Takemura, Satoshi Yamamoto, Seikan Hai, Tsuyoshi Ichikawa, Shintaro Kodai, Shinkawa Hiroji, Taichi Shuto, Kazuhiro Hirohashi, Hiromu Tanaka.   

Abstract

BACKGROUND/AIMS: Liver resection for hepatocellular carcinoma in patients with cirrhosis carries risk of major hemorrhage and sometimes requires blood transfusion. We investigated risk factors for massive blood loss during liver resection and indications for storing blood for autologous intraoperative transfusion.
METHODOLOGY: We analyzed clinical records of 100 patients with cirrhosis who underwent liver resection for hepatocellular carcinoma. Autologous blood was stored preoperatively for 19 patients.
RESULTS: Intraoperative blood loss ranged from 5 to 3000 mL (mean, 640). Liver resection was performed without transfusion in 67 patients and with autologous blood storage in 17 patients not receiving homologous blood. In the other 16 patients, homologous blood was transfused. Univariate analysis identified youth, large tumors (> 4cm), major hepatectomy, portal tumor involvement, hepatic vein involvement, and prolonged operation time as risk factors for massive blood loss; multivariate analysis identified portal involvement and hepatic vein involvement as independent risk factors. Blood loss exceeded 1000 mL in the 4 transfused group B patients and 3 of the 4 patients had hepatic vein involvement.
CONCLUSIONS: Portal involvement and hepatic vein involvement were risk factors for massive blood loss during liver resection for hepatocellular carcinoma in patients with cirrhosis. Autologous blood storage is indicated in patients with such risk factors.

Entities:  

Mesh:

Year:  2007        PMID: 17591073

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Resection of a giant hepatocellular carcinoma weighing over ten kilograms.

Authors:  Ming-Chen Ba; Shu-Zhong Cui; Sheng-Qu Lin; Yun-Qiang Tang; Yin-Bing Wu; Xiang-Liang Zhang
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

Review 2.  A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery.

Authors:  Chris D Mann; Tom Palser; Chris D Briggs; Iain Cameron; Myrrdin Rees; John Buckles; David P Berry
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

Review 3.  Procedure-related bleeding risk in patients with cirrhosis and severe thrombocytopenia.

Authors:  Domenico Alvaro; Nicola Caporaso; Edoardo Giovanni Giannini; Angelo Iacobellis; Mariacristina Morelli; Pierluigi Toniutto; Francesco Violi
Journal:  Eur J Clin Invest       Date:  2021-02-26       Impact factor: 4.686

4.  Differentiation of bland from neoplastic thrombus of the portal vein in patients with hepatocellular carcinoma: application of susceptibility-weighted MR imaging.

Authors:  Chuanming Li; Jiani Hu; Daiquan Zhou; Jun Zhao; Kuansheng Ma; Xuntao Yin; Jian Wang
Journal:  BMC Cancer       Date:  2014-08-15       Impact factor: 4.430

5.  A randomized controlled trial to compare the efficacy of regenerated and non-regenerated oxidized cellulose gauze for the secondary treatment of local bleeding in patients undergoing hepatic resection.

Authors:  Chengshuo Zhang; Dazhi Fu; Fengshan Wang; Xinping Zhong; Lei Yang; Gang Wu; Baifeng Li; Jialin Zhang
Journal:  Ann Surg Treat Res       Date:  2021-03-30       Impact factor: 1.859

6.  A multicenter, prospective, randomized clinical trial of marine mussel-inspired adhesive hemostatic materials, InnoSEAL Plus.

Authors:  Gyu-Seong Choi; Seoung Hoon Kim; Hyung Il Seo; Je Ho Ryu; Sung Pil Yun; Mi-Young Koh; Moon Sue Lee; Haeshin Lee; Jae Hun Kim
Journal:  Ann Surg Treat Res       Date:  2021-10-29       Impact factor: 1.859

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.